Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Ajanta Pharma Limited ( (IN:AJANTPHARM) ) just unveiled an update.
Ajanta Pharma has announced its participation in multiple investor and analyst conferences in February 2026, including Axis Capital’s Flagship India Conference at Trident, BKC, and the Nuvama India Conference 2026 and Kotak Flagship Conference 2026, both at the Grand Hyatt in Santacruz, Mumbai. The meetings, which will include group and one-on-one interactions with analysts and institutional investors, are intended to enhance engagement with the financial community and will be limited to discussions based on information already in the public domain, underscoring the company’s adherence to disclosure regulations and its efforts to maintain transparency with stakeholders.
More about Ajanta Pharma Limited
Ajanta Pharma Limited is an India-based pharmaceutical company headquartered in Mumbai, operating in the branded generics and specialty formulations space. It focuses on developing, manufacturing, and marketing pharmaceutical products across key therapeutic segments for domestic and international markets.
Average Trading Volume: 7,910
Technical Sentiment Signal: Strong Buy
Current Market Cap: 347.8B INR
Find detailed analytics on AJANTPHARM stock on TipRanks’ Stock Analysis page.